These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 93178)

  • 1. [Immunocellular response to fetal antigens in patients with hepatoma (author's transl)].
    Uribarrena R; Pérez Miranda M; Pons F; Amézaga A; Cabarcos A
    Med Clin (Barc); 1979 Nov; 73(8):327-33. PubMed ID: 93178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [alpha 1-fetoprotein and Tennessee antigen in hepatocellular carcinomas and in metastatic liver cancer (author's transl)].
    Polterauer P; Müller M
    Wien Klin Wochenschr; 1982 Feb; 94(4):102-5. PubMed ID: 6177106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
    Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M
    Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological differences between patients with cirrhosis and liver carcinoma].
    Sebastián Domingo JJ; Velo Bellver JL; Santos Castro L; De Diego Lorenzo A; Jimena JD; Sarriá M; Plata JL
    Rev Esp Enferm Dig; 1990 Jun; 77(6):415-8. PubMed ID: 2171603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
    Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
    Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic and immuno-histochemical determination of alpha l-fetoprotein and HBs antigens in hepatocellular carcinoma].
    Perisić-Savić M; Perisić V; Sinćić M; Janev A; Nastić-Mirić D
    Srp Arh Celok Lek; 1981; 109(5-6):775-82. PubMed ID: 6179170
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
    Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
    Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M
    J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
    Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
    Cai XY; Qiu SJ; Wu ZQ; Ye SL; Fan J; Zhou J; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):671-5. PubMed ID: 15932729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
    Bei R; Budillon A; Reale MG; Capuano G; Pomponi D; Budillon G; Frati L; Muraro R
    Cancer Res; 1999 Nov; 59(21):5471-4. PubMed ID: 10554020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for immunotherapy in hepatocellular carcinoma?
    Zerbini A; Pilli M; Ferrari C; Missale G
    Dig Liver Dis; 2006 Apr; 38(4):221-5. PubMed ID: 16461021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
    Butterfield LH; Ribas A; Meng WS; Dissette VB; Amarnani S; Vu HT; Seja E; Todd K; Glaspy JA; McBride WH; Economou JS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5902-8. PubMed ID: 14676113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
    Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
    Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.